Jeffrey Arcara
Fortuna: - $ al 30/09/2026
Fortuna: - $ al 30/09/2026
Jeffrey S.
Arcara is Chief Business Officer & Senior Vice President at Corvus Pharmaceuticals, Inc. since 2024.
Formerly, Mr. Arcara was Vice President-Business Development at Neuromed Pharmaceuticals Ltd. Education includes an undergraduate degree from the University of Wisconsin and an MBA from UCLA Anderson School of Management.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 04/12/2025 | 0 ( -.--% ) | - $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CORVUS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 06/02/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
Neuromed Pharmaceuticals Ltd.
Neuromed Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops chronic pain drugs | Corporate Officer/Principal | 27/01/2010 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Corvus Pharmaceuticals, Inc.
Corvus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides anticancer immuno-oncology drugs | Health Technology |
University of Wisconsin
University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neuromed Pharmaceuticals Ltd.
Neuromed Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops chronic pain drugs | Health Technology |
UCLA Anderson School of Management
UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.